| Year |
Citation |
Score |
| 1995 |
Mao J, Pacheco CR, Traficante DD, Rosen W. Analysis of Benzoquinolines and Acridines in a Brazilian Diesel Oil by Particle Beam LC/MS and HPLC/UV Journal of Liquid Chromatography & Related Technologies. 18: 903-916. DOI: 10.1080/10826079508010401 |
0.6 |
|
| 1995 |
Mao J, Pacheco CR, Traficante DD, Rosen W. Identification and characterization of nitrogen compounds in Brazilian diesel oil by particle beam l.c.-m.s. Fuel. 74: 880-887. DOI: 10.1016/0016-2361(95)93942-7 |
0.599 |
|
| 1994 |
Mao J, Dennis MW, Foster R, Fackler PH. Analysis of d1ethylenetriamine in water and soil at ppb levels by high performance liquid chromatography with fluorescence detection Journal of Liquid Chromatography. 17: 2485-2494. DOI: 10.1080/10826079408013495 |
0.428 |
|
| 1994 |
Mao J, Pacheco CR, Traficante DD, Rosen W. Analysis of neutral nitrogen compounds in diesel oil by direct injection high-performance liquid chromatography—mass spectrometry—ultraviolet spectrometry methods Journal of Chromatography A. 684: 103-111. DOI: 10.1016/S0021-9673(94)89136-2 |
0.598 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2002 |
Mao J, Xu Y, Wu D, Almassain B. Pharmacokinetics, mass balance, and tissue distribution of a novel DNA alkylating agent, VNP40101M, in rat. Aaps Pharmsci. 4: E24. PMID 12645996 DOI: 10.1208/ps040424 |
0.189 |
|
| 2002 |
Feun L, Modiano M, Lee K, Mao J, Marini A, Savaraj N, Plezia P, Almassian B, Colacino E, Fischer J, MacDonald S. Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule. Cancer Chemotherapy and Pharmacology. 50: 223-9. PMID 12203104 DOI: 10.1007/S00280-002-0480-0 |
0.178 |
|
| 2004 |
Pierra C, Benzaria S, Dukhan D, Loi AG, La Colla P, Bridges E, Mao J, Standring D, Sommadossi JP, Gosselin G. Synthesis, physicochemical and pharmacokinetic studies of potential prodrugs of beta-L-2'-deoxycytidine, a selective and specific anti-HBV agent. Antiviral Chemistry & Chemotherapy. 15: 269-79. PMID 15535049 DOI: 10.1177/095632020401500506 |
0.135 |
|
| 2007 |
Benzaria S, Bardiot D, Bouisset T, Counor C, Rabeson C, Pierra C, Storer R, Loi AG, Cadeddu A, Mura M, Musiu C, Liuzzi M, Loddo R, Bergelson S, Bichko V, ... ... Mao J, et al. 2'-C-Methyl branched pyrimidine ribonucleoside analogues: potent inhibitors of RNA virus replication. Antiviral Chemistry & Chemotherapy. 18: 225-42. PMID 17907380 |
0.118 |
|
| 2002 |
Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, Freezer LJ, Morton KE, Seipp C, Haworth L, Mavroukakis S, ... ... Mao J, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 142-52. PMID 11773163 |
0.108 |
|
| 2021 |
Li C, Wu M, Zhang H, Mai J, Yang L, Ding Y, Niu J, Mao J, Wu W, Zhang D, Tang Y, Yan W. Safety, tolerability, and pharmacokinetics of the novel hepatitis B virus capsid assembly modulator GST-HG141 in healthy Chinese subjects: a first-in-human single- and multiple-dose escalation trial. Antimicrobial Agents and Chemotherapy. AAC0122021. PMID 34280012 DOI: 10.1128/AAC.01220-21 |
0.107 |
|
| 2023 |
Zhang H, Zhou J, Chen H, Mao J, Tang Y, Yan W, Zhang T, Li C, Chen S, Li G, Zhang G, Ding Y, Liu L. Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial Agents and Chemotherapy. e0111523. PMID 38099673 DOI: 10.1128/aac.01115-23 |
0.102 |
|
| 2019 |
Shore N, Mincik I, DeGuenther M, Student V, Jievaltas M, Patockova J, Simpson K, Hu CH, Huang ST, Li Y, Lee Y, Chien B, Mao J. A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients. World Journal of Urology. PMID 30941562 DOI: 10.1007/s00345-019-02741-7 |
0.09 |
|
| 2022 |
Li X, Liu Y, Yao H, Wang M, Gao L, Lou J, Mao J, Wu W, Zhou Y, Tang Y, Yan W, Hu Y, Ding C, Chen S, Niu J, et al. Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial. Antimicrobial Agents and Chemotherapy. e0009422. PMID 35404074 DOI: 10.1128/aac.00094-22 |
0.087 |
|
| 2006 |
Pierra C, Amador A, Benzaria S, Cretton-Scott E, D'Amours M, Mao J, Mathieu S, Moussa A, Bridges EG, Standring DN, Sommadossi JP, Storer R, Gosselin G. Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine. Journal of Medicinal Chemistry. 49: 6614-20. PMID 17064080 DOI: 10.1021/jm0603623 |
0.082 |
|
| 2022 |
Hu Y, Sun F, Yuan Q, Du J, Hu L, Gu Z, Zhou Q, Du X, He S, Sun Y, Wang Q, Fan L, Wang L, Qin S, Chen S, ... ... Mao J, et al. Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infection. Bioorganic & Medicinal Chemistry Letters. 128977. PMID 36089112 DOI: 10.1016/j.bmcl.2022.128977 |
0.04 |
|
| 2002 |
King I, Bermudes D, Lin S, Belcourt M, Pike J, Troy K, Le T, Ittensohn M, Mao J, Lang W, Runyan JD, Luo X, Li Z, Zheng LM. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. Human Gene Therapy. 13: 1225-33. PMID 12133275 DOI: 10.1089/104303402320139005 |
0.024 |
|
| 2012 |
Shefner J, Cedarbaum JM, Cudkowicz ME, Maragakis N, Lee J, Jones D, Watson ML, Mahoney K, Chen M, Saikali K, Mao J, Russell AJ, Hansen RL, Malik F, Wolff AA, et al. Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 13: 430-8. PMID 22591195 DOI: 10.3109/17482968.2012.684214 |
0.022 |
|
| 2020 |
Abd-Elaziz K, Voors-Pette C, Wang KL, Pan S, Lee Y, Mao J, Li Y, Chien B, Lau D, Diamant Z. First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects. Clinical Drug Investigation. PMID 33331980 DOI: 10.1007/s40261-020-00981-9 |
0.02 |
|
| Hide low-probability matches. |